SCHEMBL25150602

SCHEMBL25150602

CON(C)NC(=O)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.50
POLB P06746 2/20 0.50
TSHR P16473 1/20 0.50
L3MBTL1 Q9Y468 2/20 0.49
TDP1 Q9NUW8 1/20 0.49
HDAC3 O15379 1/20 0.47
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
IDO1 P14902 1/20 0.47
ALOX15 P16050 1/20 0.47
HDAC1 Q13547 1/20 0.47
CA9 Q16790 1/20 0.47
HDAC7 Q8WUI4 1/20 0.47
HDAC2 Q92769 1/20 0.47
HSD17B10 Q99714 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
NCOR2 Q9Y618 1/20 0.47
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4918743 0.80 CYP3A4 (0.46) KMT2APOLBTSHRL3MBTL1TDP1
N',N'-Dimethylbenzohydrazide SCHEMBL952727 0.79 POLB (0.56) KMT2APOLBL3MBTL1TDP1HDAC3
N',N'-Dimethylbenzohydrazide SCHEMBL27406776 0.78 POLB (0.55) KMT2APOLBL3MBTL1TDP1HDAC3
SCHEMBL11369151 0.74 TDP1 (0.59) KMT2APOLBL3MBTL1TDP1HDAC3
SCHEMBL10449073 0.74 POLB (0.61) POLBL3MBTL1TDP1HDAC3CA12
SCHEMBL11585058 0.72 POLB (0.53) KMT2APOLBL3MBTL1TDP1HDAC3
SCHEMBL14617232 0.72 KDM4E (0.49) KMT2APOLBL3MBTL1TDP1HDAC3
SCHEMBL810200 0.71 ALDH1A1 (0.61) KMT2APOLBTSHRHDAC3CA12
SCHEMBL6885505 0.71 TSHR (0.58) KMT2APOLBTSHRTDP1HDAC3
SCHEMBL9516913 0.71 L3MBTL1 (0.58) POLBL3MBTL1TDP1HDAC3CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023064164-A1 CHIMERIC COMPOUNDS USEFUL IN TREATING DISEASES PADARN THERAPEUTICS, INC. (US) 2023-04-20 WO disclosed